KLISBio

Milan, Italy · Founded 2014 · Privately Held (backing)

Developer of an innovative medical technology designed to find new tissue regeneration methods. KLISBio is based in Milan, Italy and was founded in 2014. Its last reported valuation was $34.9 million in Dec 2022. It has raised $27.3 million.

Last reported valuation
$34.9M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
—

Who backs KLISBio?

15 investors
InvestorType
European Innovation CouncilVenture capital
CDP Venture Capital (Rome)Venture capital
Primo Capital (Milano)Venture capital
Anya Capital—
Enea Tech e BiomedicalOther
Angels for Impact—
ComoNext—
ENEA Tech Biomedical—
European Innovation Council (Belgium)—
Horizon 2020—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

KLISBio investors

15 investors are on record for KLISBio, including European Innovation Council, CDP Venture Capital (Rome), Primo Capital (Milano) and Anya Capital.

Free account
More of KLISBio with a free account
  • ·The complete investor list: 15 names
  • ·Watch KLISBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like KLISBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View